eISSN: 2300-6722
ISSN: 1899-1874
Medical Studies/Studia Medyczne
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
4/2013
vol. 29
 
Share:
Share:
abstract:
Review paper

Sudden cardiac death – what do we know and how do we prevent it?

Łukasz Zandecki
,
Marcin Sadowski
,
Szymon Domagała
,
Agnieszka Łętek
,
Marianna Janion

Studia Medyczne 2013; 29 (4): 328–337
Online publish date: 2013/12/30
View full text Get citation
 
PlumX metrics:
Sudden cardiac death (SCD) is an important clinical problem with a complex and multifactor background. Trends in its prevention have been dynamically developing over the last decades. Patients with ischemic heart disease, especially after myocardial infarction, represent the largest group at an elevated risk of SCD. Many congenital and hereditary diseases are associated with an increased risk of SCD, particularly among young people. Although far from perfect, left ventricular ejection fraction remains the only widely recognized, relatively objective and credible method of assessing the risk of SCD among patients with heart failure. Other methods for assessing the risk are waiting for the final confirmation of their usefulness in clinical trials. The implantable cardioverter-defibrillator (ICD) and its newer version – totally subcutaneous S-ICD – remain the most effective methods of SCD prevention. The only class of drugs with well-proven efficiency in most patients at risk of SCD is β-blockers.
keywords:

sudden cardiac death, SCD, risk of SCD, prevention of SCD

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.